Treatment of aspergillus-related ulcerative tracheobronchitis in lung transplant recipients.
Birsan
T
T
Taghavi
S
S
Klepetko
W
W
D000328:Adult; D000336:Aerosols; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000714:Anastomosis, Surgical / Q000009:adverse effects; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage / Q000627:therapeutic use; D016040:Lung Transplantation / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D013530:Surgical Wound Infection / Q000188:drug therapy*; D014136:Tracheitis / Q000188:drug therapy / Q000382:microbiology*; D014456:Ulcer / Q000188:drug therapy / Q000382:microbiology
D000336:Aerosols; D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B